Lili Nsongo Analyst PerformanceBiotechnology Equity Research Vice President at Leerink PartnersLili Nsongo is a stock analyst at Leerink Partners in the healthcare sector, covering 4 publicly traded companies. Over the past year, Lili Nsongo has issued 3 stock ratings, including and buy recommendations. While full access to Lili Nsongo's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Lili Nsongo's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings6 Last 2 YearsBuy Recommendations100.00% 6 Buy RatingsCompanies Covered4 Unique Companies Ratings Distribution6RatingsDistribution of strong buy, buy, hold, and sell ratings by Lili Nsongo.RatingPercentageCount Strong Buy33.3%2 ratings Buy66.7%4 ratings Hold0.0%0 ratings Sell0.0%0 ratingsOut of 6 total stock ratings issued by Lili Nsongo at Leerink Partners, the majority (66.7%) have been Buy recommendations, followed by 33.3% Strong Buy.Best & Worst CallsBest Call000.0%ARCTAug 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ARCTAug 2024Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ4 companiesLili Nsongo, an analyst at Leerink Partners, currently covers 4 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare4 companies100.0%Lili Nsongo of Leerink Partners specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY4 companies100.0% Lili Nsongo's Ratings History at Leerink Partners Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsENGNenGene11/13/2026Upgrade$2.28$5.00Outperform$0.0000.00% ROIARCTArcturus Therapeutics10/9/2026Boost Price Target$12.87$19.00Outperform$0.0000.00% ROIIRDOpus Genetics5/21/2026Initiated Coverage$4.44$10.00Outperform$0.0000.00% ROIARCTArcturus Therapeutics8/22/2025Lower Price Target$18.47$54.00Outperform$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche BankBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
